✦ LIBER ✦

Bone density consequences of initiation and compliance with therapy for osteoporosis

✍ Scribed by Robert A. Yood; Susan E. Andrade; Kathleen M. Mazor; Hassan Fouayzi; Wing Chan; Kristijan Kahler

Publisher: Wiley (John Wiley & Sons)
Year: 2010
Tongue: English
Weight: 89 KB
Volume: 62
Category: Article
ISSN: 2151-464X
DOI: 10.1002/acr.20261

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Larger increases in bone mineral density

Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis

✍ Marc C. Hochberg; Philip D. Ross; Dennis Black; Steven R. Cummings; Harry K. Gen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

Measurement of bone density: Comment on

Measurement of bone density: Comment on the american college of rheumatology recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

✍ Harvey A. Schwartz 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Bone mineral density and frequency of os

Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County rheumatoid arthritis register

✍ Glenn Haugeberg; Till Uhlig; Jan A. Falch; Johan I. Halse; Tore K. Kvien 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

The effect of combined androgen blockade

The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma : Longitudinal evaluation and response to intermittent cyclic etidronate therapy

✍ Terrence Diamond; Joanne Campbell; Carl Bryant; William Lynch 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

## BACKGROUND. Androgen receptor blocking agents have become an established form of therapy for men with disseminated prostate carcinoma. The purpose of this study was to evaluate markers of bone turnover and to measure bone mineral densities (BMD) in men with disseminated prostate carcinoma treat

Prevalence of and risk factors for low b

Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus

✍ Irene E. M. Bultink; Willem F. Lems; Piet J. Kostense; Ben A. C. Dijkmans; Alexa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 2 views

## Abstract ## Objective To examine the prevalence of and risk factors for low bone mineral density (BMD) and vertebral fractures in patients with systemic lupus erythematosus (SLE). ## Methods We studied 107 SLE patients. Demographic and clinical data were collected, and radiographs of the thor

Exacerbation of coagulopathy with concur

Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia

✍ Gavin M. Cull; John W. Eikelboom; Paul K. Cannell 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB 👁 2 views

A 22-year-old female presented with acute promyelocytic leukemia (APL). Treatment with all-trans retinoic acid (ATRA) resulted in a severe exacerbation of the coagulopathy 5 days after its introduction. This was complicated by bone marrow necrosis, parenchymal liver damage and acute tubular necrosis